EMEA Thought Leadership

Microbiome therapeutics could be the next big thing in pharma | June 2023
Source: Healthcare Brew
The microbiome-based therapeutic market is expected to be worth $1.6 billion by 2026. Interest in this field is growing, especially with two drugs targeting the microbiome being approved in the past year. What is the outlook for the microbiome?

Nine for 2023, part one: a reflection on inflection | January 2023
Source: Pharmaphorum
The first in a 3-part series on what trends will be affecting the pharma and life sciences industries in the upcoming year. This first part focuses on global healthcare environmental challenges and what they mean for the pharmaceutical industry.

Nine for 2023, part two: healthcare’s hard problem, the prognosis for diagnosis, and key new pharmacotherapy platforms | January 2023
Source: Pharmaphorum
This second part of the 3-part series focuses on opportunities for pharma; the unmet need which lies at the heart of better healthcare provision, Point of Care Diagnostics and new pharmacotherapy classes becoming commercially available in 2023.

Nine for 2023, part three: surviving or thriving? | January 2023
Source: Pharmaphorum
This final part of the 3-part series concerns issues that will change the direction of healthcare and the pharmaceutical industry this year, with three key competitive issues for pharmaceutical companies in 2023 being assessed.

3 ways healthcare systems can reduce their carbon footprint | November 2022
Source: World Economic Forum
Rapid climate change has a direct impact on human health. The risk to human health bears down heavily upon healthcare systems. What can be done by these systems to reduce their carbon emissions?

“Your order has been dispatched”: Moving patient care closer to the home | October 2022
Source: Medhealth Outlook
Healthcare has increasingly moved towards treating patients at an individual level. As part of this phenomena there is a growing focus on providing patients greater flexibility on the location and timing of how they receive care. Learn how pharma and others can success during this change.

Is the launch environment really more competitive now? | October 2022
Source: Pharmaphorum
It’s often stated - mostly without reference to data - that the environment for innovative launches is more competitive now than it ever has been. Is this true? We interrogate this claim using IQVIA’s long term market data to analyse nearly 30 years of launches.

How can countries achieve digital maturity in healthcare? | August 2022
Source: World Economic Forum
Healthcare systems are becoming increasingly digitised, but this trend has accelerated in the last 10 years, as well as been given a huge boost by the COVID-19 pandemic. Progression towards digital maturity is uneven between countries, but there are successful examples to follow.

How clinical development can tackle Africa's unique health needs | May 2022
Source: World Economic Forum
By 2050, the United Nations projects that 25% of all humanity will be African, with non-communicable diseases poised to become the leading cause of deaths in sub-Saharan Africa. The poor level of commercially led clinical development activity in Africa must be addressed considering these changing factors.